Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
95259 trials found · Page 162 of 4763
-
Personalized heart procedure may beat standard treatment for AFib
Disease control Recruiting nowAtrial fibrillation (AF) is a common heart rhythm disorder affecting over a million people in North America and is associated with serious complications including stroke, heart failure, reduced quality of life, and premature death. Catheter ablation has been shown to be more effe…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Hope for VHL patients: Long-Term belzutifan trial tracks survival
Disease control Recruiting nowResearchers are looking for new ways to treat advanced solid tumors and von Hippel-Lindau (VHL)-related tumors: * Advanced means the cancer has spread to other parts of the body (metastatic) or cannot be removed with surgery * Solid tumors are cancers mostly in body organs and t…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New drug cocktail aims to shrink rectal tumors before surgery
Disease control Recruiting nowThe study is being conducted to evaluate the safety and efficacy of Adebrelimab and SHR-8068 in combination with chemoradiotherapy in subjects with rectal cancer.
Phase: PHASE2, PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 16, 2026 19:56 UTC
-
New cocktail therapy targets liver tumors in pancreatic cancer patients
Disease control Recruiting nowThis Phase II clinical study evaluates the safety and efficacy of a combination therapy for patients with pancreatic cancer that has spread to the liver. Because liver metastases are a major factor in the progression of pancreatic cancer, this research utilizes Hepatic Arterial I…
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
New combo therapy shows promise for rare blood cancer
Disease control Not yet recruitingThis is a multicenter, open-label, phase Ib/II study evaluating tislelizumab in combination with zeprumetostat (SHR2554) in patients with relapsed or refractory NK/T-cell lymphoma after at least one prior asparaginase-based chemotherapy-containing regimen, with or without radioth…
Phase: PHASE1, PHASE2 • Sponsor: Rong Tao • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New hope for refractory lymphoma: tailored drug cocktail targets resistant cancer
Disease control Not yet recruitingTo evaluate the safety and efficacy of Zeprumetostat-based combination therapy, selected according to genotyping results, in patients with primary refractory peripheral T-cell lymphoma (PTCL).
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New weapon against superbugs: gut cleanse trial launches
Disease control ENROLLING_BY_INVITATIONA clinical study to eliminate intestinal colonization in subjects harboring microorganisms resistant to carbapenem and vancomycin antibiotics, thereby treating infections caused by these microorganisms.
Phase: NA • Sponsor: BioMe Inc. • Aim: Disease control
Last updated May 16, 2026 19:53 UTC
-
New pill may replace steroids for severe UC flares
Disease control Recruiting nowThe goal of this clinical trial is to learn comparative effectiveness and safety of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis. The main questions it aims to answer are: 1. Whether upadacitinib can effectively induce remission in ac…
Phase: PHASE4 • Sponsor: Yongquan Shi • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
Engineered immune cells take on autoimmune diseases
Disease control Not yet recruitingThis study is an investigator-initiated single center, single arm clinical study with a target population of patients with refractory autoimmune diseases. It is an early exploratory clinical study of the safety, tolerability and initial efficacy of CD19/BCMA CAR-T in the treatmen…
Phase: NA • Sponsor: Shenzhen Genocury Biotech Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
New vaccine trial aims to shield infants from deadly meningitis
⭐️ VACCINE ⭐️ Not yet recruitingThe goal of this clinical trial is to evaluate the immunogenicity, safety, and immune persistence of the primary series of an investigational group ACYW135 meningococcal conjugate vaccine, as well as the immunogenicity and safety of a booster dose administered at 12 months of age…
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:55 UTC
-
New meningitis vaccine trial for infants could offer better protection
⭐️ VACCINE ⭐️ Not yet recruitingThe goal of this clinical trial is to evaluate the immunogenicity, safety, and persistence of the immune response of a group ACYW135 meningococcal conjugate vaccine in healthy children aged 6 to 11 months. The main questions it aims to answer are: Is the immune response induced…
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 16, 2026 19:56 UTC
-
New meningitis vaccine trial aims to protect young children
⭐️ VACCINE ⭐️ Not yet recruitingThe goal of this clinical trial is to evaluate the immunogenicity and safety of an investigational group ACYW135 meningococcal conjugate vaccine in healthy children aged 2 to 6 years. The main questions it aims to answer are: Is the immune response induced by the investigationa…
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 14, 2026 12:02 UTC
-
New meningitis vaccine for toddlers shows promise in major trial
⭐️ VACCINE ⭐️ Not yet recruitingThe goal of this clinical trial is to evaluate the immunogenicity and safety of an investigational group ACYW135 Meningococcal conjugate vaccine in healthy children aged 12 to 23 months. The main questions it aims to answer are: Is the immune response induced by the investigati…
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 07, 2026 18:41 UTC
-
New shot could bring relief to teens with severe eczema
Disease control Recruiting nowThis trial was designed to evaluate the efficacy and safety of SHR-1819 in adolescents with moderate-to-severe atopic dermatitis.
Phase: PHASE3 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 16, 2026 19:51 UTC
-
New brain radiation combo aims to control tumors and save memory
Disease control Recruiting nowThis is a phase 3, randomized, controlled clinical trial comparing two brain-directed treatment strategies for adult patients with extensive brain metastases from lung adenocarcinoma. The trial compares fractionated stereotactic radiotherapy combined with bevacizumab (FSRT-Bev) v…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New vaccine aims to train immune system against aggressive breast cancer
⭐️ VACCINE ⭐️ Recruiting nowThis phase II trial studies how well a cancer vaccine called STEMVAC works in combination with chemotherapy in treating patients with PD-L1 negative, triple-negative breast cancer that has spread from where it first started (primary site) to other places in the body (metastatic).…
Phase: PHASE2 • Sponsor: University of Washington • Aim: ⭐️ VACCINE ⭐️
Last updated May 16, 2026 19:53 UTC
-
New drug combo targets deadly brain tumors in early trial
Disease control TerminatedThe objective of this pilot study is to evaluate the efficacy of adding S-Gboxin to standard RT/TMZ treatment protocols in patients with glioblastoma multiforme (GBM) or midline glioma (DMG), regardless of their mutation status
Phase: PHASE1 • Sponsor: Petrov, Andrey • Aim: Disease control
Last updated May 16, 2026 19:53 UTC
-
New malaria vaccine put to the test in Real-World trial
⭐️ VACCINE ⭐️ Not yet recruitingThe goal of the study is to test the efficacy using a homologous CHMI of this vaccine candidate early in the development path in a population living in malaria-endemic areas. In the previous Phase Ia and Ib trials, no efficacy endpoints were defined, and therefore there is curre…
Phase: PHASE1 • Sponsor: European Vaccine Initiative • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:53 UTC
-
New hope for stroke patients: safer blood thinner may prevent second blockage
Disease control CompletedPatients with tandem lesions (TL) are defined as patients with an acute ischemic stroke (AIS) with occlusion of an intracranial vessel of the anterior circulation and an occlusion or severe stenosis (70-99%) of the origin of the ipsilateral internal carotid artery (ICA). The grea…
Phase: PHASE4 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New zap without surgery could ease Parkinson's symptoms
Symptom relief Not yet recruitingParkinson's disease (PD) is a neurodegenerative disorder characterized by motor dysfunction. While deep brain stimulation (DBS) is effective, its invasive nature limits its application in early-stage patients. Temporal interference stimulation (TIS) is a novel non-invasive techni…
Phase: NA • Sponsor: Jiangsu Province Nanjing Brain Hospital • Aim: Symptom relief
Last updated May 16, 2026 19:55 UTC